First Trust NYSE Arca Biotechnology UCITS ETF

First Trust NYSE Arca Biotechnology UCITS ETF is an investment fund structure domiciled in Dublin, Ireland. Funds hold LEIs in their own right, and GLEIF records who manages them rather than who owns them.

The LEI has been on record for 6 years, since 23 Dec 2019. That puts it right on the median for Ireland, where half of all LEIs date from before 2019.

The next annual re-validation is due 22 Aug 2027, 284 days from now.

This archive holds 2 versions of the record. The most recent change was on 4 Aug 2026 and altered the next renewal; the oldest version we hold dates from 6 Jul 2026. GLEIF publishes only the current state, so superseded values are not available from the source.

The entity is registered with Registers for financial service providers and collective investment schemes under registry number C419554, and the LEI itself is issued and maintained by Bloomberg Finance L.P., one of the Local Operating Units accredited by GLEIF.

No direct accounting-consolidating parent is reported, because no parent prepares consolidated accounts that include it. GLEIF requires this to be stated explicitly rather than left blank, so the absence is itself a data point.

No ultimate accounting-consolidating parent is reported, because no parent prepares consolidated accounts that include it. GLEIF requires this to be stated explicitly rather than left blank, so the absence is itself a data point.

The LEI registration is issued, and the entity status (active) records whether the legal entity itself still exists. The two are independent: an LEI can lapse while the company trades on, and it can stay issued after the company has been dissolved.